UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 96 filers reported holding UNIQURE NV in Q4 2018. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666,974 | -36.7% | 99,400 | +8.0% | 0.00% | 0.0% |
| Q2 2023 | $1,054,320 | -42.5% | 92,000 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $1,832,740 | -20.4% | 91,000 | -10.3% | 0.00% | -50.0% |
| Q4 2022 | $2,301,005 | +23.2% | 101,500 | +1.9% | 0.00% | +100.0% |
| Q3 2022 | $1,868,000 | +2.2% | 99,600 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $1,827,000 | +23.3% | 98,000 | +19.5% | 0.00% | 0.0% |
| Q1 2022 | $1,482,000 | -6.3% | 82,000 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $1,582,000 | -35.2% | 76,300 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $2,442,000 | +7.7% | 76,300 | +3.7% | 0.00% | +100.0% |
| Q2 2021 | $2,267,000 | -11.8% | 73,600 | -3.5% | 0.00% | -50.0% |
| Q1 2021 | $2,571,000 | -5.5% | 76,300 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $2,721,000 | -1.9% | 75,300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,773,000 | -15.8% | 75,300 | +3.0% | 0.00% | -33.3% |
| Q2 2020 | $3,294,000 | +2.6% | 73,100 | +8.0% | 0.00% | 0.0% |
| Q1 2020 | $3,212,000 | -31.6% | 67,700 | +3.4% | 0.00% | -40.0% |
| Q4 2019 | $4,694,000 | +86.0% | 65,500 | +2.2% | 0.01% | +66.7% |
| Q3 2019 | $2,523,000 | -38.5% | 64,100 | +22.1% | 0.00% | -25.0% |
| Q2 2019 | $4,103,000 | +55.6% | 52,500 | +18.8% | 0.00% | +33.3% |
| Q1 2019 | $2,637,000 | +114.2% | 44,200 | +3.5% | 0.00% | +50.0% |
| Q4 2018 | $1,231,000 | -17.5% | 42,700 | +4.1% | 0.00% | 0.0% |
| Q3 2018 | $1,492,000 | -3.7% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,550,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |